Skip to main content

Fate Therapeutics Inc

FATE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001434316

In the last 90 days, Fate Therapeutics Inc insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $193.2M in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in Fate Therapeutics Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
249
+1 vs. Q4 2021
Shares held
101.1M
+4.31M (+4.4%) vs. Q4 2021
Total value
$3.92B
−$1.74B (−30.8%) vs. Q4 2021
New holders
36
101 more added
Sold out
35
71 more reduced

2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting FATE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 249 institutions
Q1 2021: 260 institutionsQ2 2021: 272 institutionsQ3 2021: 266 institutionsQ4 2021: 250 institutionsQ1 2022: 249 institutionsQ2 2022: 233 institutionsQ3 2022: 239 institutionsQ4 2022: 228 institutionsQ1 2023: 182 institutionsQ2 2023: 188 institutionsQ3 2023: 171 institutionsQ4 2023: 159 institutionsQ1 2024: 167 institutionsQ2 2024: 182 institutionsQ3 2024: 164 institutionsQ4 2024: 159 institutionsQ1 2025: 132 institutionsQ2 2025: 139 institutionsQ3 2025: 143 institutionsQ4 2025: 146 institutionsQ1 2026: 158 institutionsQ2 2026: 156 institutions
Value heldQ1 2022: $3.92B
Q1 2021: $7.73BQ2 2021: $8.20BQ3 2021: $5.67BQ4 2021: $5.66BQ1 2022: $3.92BQ2 2022: $2.70BQ3 2022: $2.41BQ4 2022: $1.07BQ1 2023: $641.6MQ2 2023: $519.6MQ3 2023: $202.9MQ4 2023: $357.2MQ1 2024: $904.0MQ2 2024: $401.1MQ3 2024: $401.6MQ4 2024: $166.5MQ1 2025: $76.3MQ2 2025: $88.9MQ3 2025: $101.6MQ4 2025: $70.9MQ1 2026: $88.9MQ2 2026: $193.2M
Institutions holding FATE and their total value by quarter
QuarterHoldersValue
Q2 2026156$193.2M
Q1 2026158$88.9M
Q4 2025146$70.9M
Q3 2025143$101.6M
Q2 2025139$88.9M
Q1 2025132$76.3M
Q4 2024159$166.5M
Q3 2024164$401.6M
Q2 2024182$401.1M
Q1 2024167$904.0M
Q4 2023159$357.2M
Q3 2023171$202.9M
Q2 2023188$519.6M
Q1 2023182$641.6M
Q4 2022228$1.07B
Q3 2022239$2.41B
Q2 2022233$2.70B
Q1 2022249$3.92B
Q4 2021250$5.66B
Q3 2021266$5.67B
Q2 2021272$8.20B
Q1 2021260$7.73B

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Fate Therapeutics Inc; share changes are against Q4 2021.

Institutions holding FATE in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Allspring Global Investments Holdings, LLC240,327$9.32M0.01%−3,520−1.4%Reduced
Candriam Luxembourg S.C.A.243,440$9.44M0.06%−7,297−2.9%Reduced
Rice Hall James & Associates, LLC245,916$9.53M0.38%−4,296−1.7%Reduced
Panagora Asset Management Inc275,445$10.7M0.06%+616+0.2%Added
Millennium Management LLC310,144$12.0M0.01%+289,967+1,437.1%Added
Bank of America Corp324,111$12.6M0.00%−59,086−15.4%Reduced
Bank of New York Mellon Corp354,949$13.8M0.00%−3,446−1.0%Reduced
Neuberger Berman Group LLC358,192$13.9M0.01%+5,856+1.7%Added
Amundi357,539$14.1M0.01%−23,595−6.2%Reduced
Dimensional Fund Advisors LP389,116$15.1M0.00%−25,361−6.1%Reduced
Citadel Advisors LLC419,922$16.3M0.02%+247,765+143.9%Added
UBS Asset Management Americas Inc444,050$17.2M0.01%+16,707+3.9%Added
Eversept Partners, LP456,059$17.7M1.63%+201,269+79.0%Added
Nuveen Asset Management, LLC495,044$18.7M0.01%+36,996+8.1%Added
Boxer Capital, LLC500,000$19.4M1.00%00.0%Unchanged
DAFNA Capital Management LLC500,930$19.4M5.06%+128,770+34.6%Added
Brown Advisory Inc503,397$19.5M0.03%+236,931+88.9%Added
Norges Bank558,628$21.7M0.00%−230,826−29.2%Reduced
Franklin Resources Inc663,999$25.7M0.01%−19,373−2.8%Reduced
Wellington Management Group LLP731,125$28.3M0.00%+31,373+4.5%Added
Northern Trust Corp779,832$30.2M0.01%−32,275−4.0%Reduced
Charles Schwab Investment Management Inc815,382$31.6M0.01%+20,674+2.6%Added
Credit Suisse AG1,009,701$39.1M0.03%+11,210+1.1%Added
Invesco Ltd.1,015,117$39.4M0.01%+131,838+14.9%Added
Victory Capital Management Inc1,022,707$39.5M0.04%+67,395+7.1%Added
Grosvenor Holdings, L.L.C.1,037,256$40.2M7.85%00.0%Unchanged
Nikko Asset Management Americas, Inc.1,262,866$46.5M0.34%+20,023+1.6%Added
Westfield Capital Management Co LP1,220,321$47.3M0.30%+740,673+154.4%Added
Morgan Stanley1,231,802$47.8M0.01%−399,274−24.5%Reduced
Sumitomo Mitsui Trust Holdings, Inc.1,262,866$49.0M0.03%+20,023+1.6%Added
Pictet Asset Management SA1,358,636$52.7M0.06%−52,705−3.7%Reduced
Janus Henderson Group PLC1,469,400$57.0M0.03%−73,204−4.7%Reduced
Geode Capital Management, LLC1,474,227$57.2M0.01%+48,259+3.4%Added
FMR LLC1,615,716$62.6M0.01%−161,613−9.1%Reduced
JPMorgan Chase & Co1,861,706$72.2M0.01%−70,758−3.7%Reduced
Artal Group S.A.2,000,000$77.5M3.28%+200,000+11.1%Added
Deep Track Capital, LP2,000,000$77.5M5.01%+1,581,963+378.4%Added
Johnson & Johnson3,379,064$131.0M24.77%00.0%Unchanged
Casdin Capital, LLC3,400,000$131.8M5.91%00.0%Unchanged
State Street Corp3,472,432$134.6M0.01%+753,639+27.7%Added
Bellevue Group AG3,576,486$138.7M1.61%−199,250−5.3%Reduced
Capital World Investors4,559,673$176.8M0.03%+1,300,640+39.9%Added
Price T Rowe Associates Inc4,911,367$190.4M0.02%+977,429+24.8%Added
BlackRock Inc.7,105,671$275.5M0.01%+45,119+0.6%Added
Vanguard Group Inc7,691,172$298.2M0.01%+15,385+0.2%Added
ARK Investment Management LLCSuperinvestorARK Invest10,988,182$426.0M1.78%+676,015+6.6%Added
Redmile Group, LLC12,957,222$502.4M15.68%00.0%Unchanged
International Biotechnology Trust PLC28,000––00.0%Unchanged
Advisor Group Holdings, Inc.1,015––+3+0.3%Added
Darwin Global Management, Ltd.0$00.00%−153,537−100.0%Sold out
Integral Health Asset Management, LLC0$00.00%−130,000−100.0%Sold out
Logos Global Management LP0$00.00%−94,000−100.0%Sold out
Marshall Wace, LLP0$00.00%−74,622−100.0%Sold out
Ergoteles LLC0$00.00%−47,026−100.0%Sold out
Advisors Asset Management, Inc.0$00.00%−43,046−100.0%Sold out
Goldstream Capital Management Ltd0$00.00%−42,225−100.0%Sold out
Altrinsic Global Advisors LLC0$00.00%−27,000−100.0%Sold out
Squarepoint Ops LLC0$00.00%−25,739−100.0%Sold out
L & S Advisors Inc0$00.00%−25,513−100.0%Sold out
Jane Street Group, LLC0$00.00%−25,235−100.0%Sold out
Gyon Technologies Capital Management, LP0$00.00%−16,246−100.0%Sold out
Two Sigma Investments, LP0$00.00%−14,700−100.0%Sold out
Man Group plc0$00.00%−12,430−100.0%Sold out
Chartwell Investment Partners, LLC0$00.00%−11,708−100.0%Sold out
Pier 88 Investment Partners LLC0$00.00%−10,885−100.0%Sold out
Weiss Multi-Strategy Advisers LLC0$00.00%−8,831−100.0%Sold out
Quantamental Technologies LLC0$00.00%−5,873−100.0%Sold out
SevenBridge Financial Group, LLC0$00.00%−4,535−100.0%Sold out
O'Shaughnessy Asset Management, LLC0$00.00%−4,502−100.0%Sold out
Mackenzie Financial Corp0$00.00%−4,456−100.0%Sold out
Exencial Wealth Advisors, LLC0$00.00%−4,305−100.0%Sold out
Texas Yale Capital Corp.0$00.00%−4,000−100.0%Sold out
CIBC Asset Management Inc0$00.00%−3,868−100.0%Sold out
Xponance, Inc.0$00.00%−3,821−100.0%Sold out
Resources Investment Advisors, LLC.0$00.00%−3,419−100.0%Sold out
KRS Capital Management, LLC0$00.00%−2,150−100.0%Sold out
Eaton Vance Management0$00.00%−545−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−216−100.0%Sold out
Cutler Group LP0$00.00%−209−100.0%Sold out
Laurel Wealth Advisors LLC0$00.00%−170−100.0%Sold out
CoreCap Advisors, LLC0$00.00%−155−100.0%Sold out
Smith Group Asset Management, LLC0$00.00%−90−100.0%Sold out
Eagle Bay Advisors LLC0$00.00%−76−100.0%Sold out
Masso Torrence Wealth Management Inc.0$00.00%−50−100.0%Sold out
Tygh Capital Management, Inc.––––Not filed
Bell Investment Advisors, Inc––––Not filed